Clinical Trial Update: Facilitation of NMDA Receptor Function in Patients With Schizophrenia and Co-morbid Alcoholism [Phase 2]

View source ↗

Summary

Phase 2 trial assessing a treatment to facilitate NMDA receptor function in patients with schizophrenia and co-morbid alcoholism; study completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholism
• Schizophrenia

Snippet

Sponsor: Yale University | Conditions: Alcoholism, Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2017-04-12